阿尔茨海默氏病连续体 - 一种新的诊断方法
Jonathan Drake1, Scott Warren1, Chuang-Kuo Wu1
1Department of Neurology, Warren Alpert Medical School of Brown University; Rhode Island Hospital Alzheimer's Disease and Memory Disorders Center, Providence, RI.
Rhode Island medical journal (2013)
|April 29, 2025
概括
新的阿尔茨海默氏症是什么
科学领域:
- 神经学 神经学
- 生物标志物 生物标志物
- 疾病管理 疾病管理
背景情况:
- 随着科学进步,阿尔茨海默病 (AD) 管理正在不断发展.
- 新的疗法增加了像粉样蛋白PET成像等诊断工具的使用.
- 针对阿尔茨海默病的基于血液的生物标志物正在成为商业可用.
研究的目的:
- 引导社区从业者在做出明智的AD诊断决策.
- 为了突出AD诊断的新出现的挑战,由于先进的生物标志物可用性.
- 为导航新的AD诊断技术提供基本原则.
主要方法:
- 关于阿尔茨海默病当前科学进展的综述.
- 对FDA批准的新疗法对诊断的影响分析.
- 检查新生流体和成像生物标志物的作用.
主要成果:
- 社区从业人员面临着对高级AD生物标志物解释的越来越大的责任.
- 随时可用的先进诊断技术带来了新的决策挑战.
- 为了明智地做出AD诊断选择,需要基本原则.
结论:
- 阿尔茨海默病诊断的景观正在迅速变化.
- 医生需要最新的知识来管理不断变化的诊断选择.
- 对新的生物标志物技术的积极导向对于有效的AD护理至关重要.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315
Dementia
64
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
64
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Formulating and Validating Nursing Diagnosis II
2.5K
Nursing diagnoses represent a problem validated by major defining characteristics. There are four categories of nursing diagnoses: problem-focused, risk, health promotion or wellness, and syndrome. The anatomy of a nursing diagnosis includes three components: problem statement or diagnostic label, defining characteristics, and related factors.
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
2.5K
Cognitive Development During Adulthood
22
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
22
Diagnostic and Statistical Manual of Mental Disorders (DSM)
22
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
22


